Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo

Neurobiology of Disease

Volumn 65, Issue , 2014, Pages 25-34

  Tripathi, Vineeta Bhasker ^a   Baskaran, Pranetha ^a   Shaw, Christopher E ^a   Guthrie, Sarah ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ALS; Axon growth cytoskeleton; Chick embryo; Cytoplasmic mislocalisation; FTD TDP; Motor neuron; Neurotoxicity; TDP 43

Indexed keywords

ALS; AXON GROWTH CYTOSKELETON; CHICK EMBRYO; CYTOPLASMIC MISLOCALISATION; FTD-TDP; MOTOR NEURON; NEUROTOXICITY; TDP-43;

ANIMALS; APOPTOSIS; AXONS; CELLS, CULTURED; CEREBRAL CORTEX; CHICK EMBRYO; CYTOPLASM; DNA-BINDING PROTEINS; ELECTROPORATION; GREEN FLUORESCENT PROTEINS; IN SITU NICK-END LABELING; MUTATION; NEURONS; RATS; SPINAL CORD;

EID: 84893513429     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.01.004     Document Type: Article

References (42)

1. Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 2010, 30:639-649.
2. Blair I.P., Williams K.L., Warraich S.T., Durnall J.C., Thoeng A.D., Manavis J., Blumbergs P.C., Vucic S., Kiernan M.C., Nicholson G.A. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry 2010, 81(6):639-645.
3. Casafont I., Bengoechea R., Tapia O., Berciano M.T., Lafarga M. TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons. J. Struct. Biol. 2009, 167:235-241.
4. Chiang P.-M., Ling J., Jeong Y.H., Price D.L., Aja S.M., Wong P.C. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc. Natl. Acad. Sci. 2010, 107:16320-16324.
5. Chio A., Restagno G., Brunetti M., Ossola I., Calvo A., Mora G., Sabatelli M., Monsurro M.R., Battistini S., Mandrioli J., Salvi F., Spataro R., Schymick J., Traynor B.J., La Bella V. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol. Aging 2009, 30:1272-1275.
6. Corrado L., Del Bo R., Castellotti B., Ratti A., Cereda C., Penco S., Soraru G., Carlomagno Y., Ghezzi S., Pensato V., Colombrita C., Gagliardi S., Cozzi L., Orsetti V., Mancuso M., Siciliano G., Mazzini L., Comi G.P., Gellera C., Ceroni M., D'Alfonso S., Silani V. Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J. Med. Genet. 2010, 47(3):190-194.
7. Damme P.V., Goris A., Race V., Hersmus N., Dubois B., Bosch L.V., Matthijs G., Robberecht W. The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS. Eur. J. Neurol. 2010, 17:754-756.
8. Drepper C., Herrmann T., Wessig C., Beck M., Sendtner M. C-terminal FUS/TLS mutations in familial and sporadic ALS in Germany. Neurobiol. Aging 2011, 32:548.e1-548.e4.
9. Duan W., Guo Y., Jiang H., Yu X., Li C. MG132 enhances neurite outgrowth in neurons overexpressing mutant TAR DNA-binding protein-43 via increase of HO-1. Brain Res. 2011, 1397:1-9.
10. Fallini C., Bassell G.J., Rossoll W. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum. Mol. Genet. 2012, 21:3703-3718.
11. Feiguin F., Godena V.K., Romano G., D'Ambrogio A., Klima R., Baralle F.E. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009, 583:1586-1592.
12. Forman M.S., Trojanowski J.Q., Lee V.M. TDP-43: a novel neurodegenerative proteinopathy. Curr. Opin. Neurobiol. 2007, 17:548-555.
13. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 2008, 63:535-538.
14. Godena V.K., Romano G., Romano M., Appocher C., Klima R., Buratti E., Baralle F.E., Feiguin F. TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization. PLoS One 2011, 6. (e17808-e17808).
15. Hamburger V., Hamilton H.L. A series of normal stages in the development of the chick embryo. J. Morphol. 1951, 88:49-92.
16. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
17. Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Bel Hadj S., Durham H.D., Vande Velde C., Rouleau G.A., Drapeau P. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2010, 19:671-683.
18. Kraemer B., Schuck T., Wheeler J., Robinson L., Trojanowski J., Lee V., Schellenberg G. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010, 119:409-419.
19. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
20. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136:1001-1004.
21. Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., Eisen A., McClusky L., Kretzschmar H.A., Monoranu C.M., JR H, Kirby J., Siddique T., Shaw P.J., Lee V.M., Trojanowski J.Q. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007, 61:427-434.
22. Miyake N., Chilton J., Psatha M., Cheng L., Andrews C., Chan W.M., Law K., Crosier M., Lindsay S., Cheung M., Allen J., Gutowski N.J., Ellard S., Young E., Iannaccone A., Appukuttan B., Stout J.T., Christiansen S., Ciccarelli M.L., Baldi A., Campioni M., Zenteno J.C., Davenport D., Mariani L.E., Sahin M., Guthrie S., Engle E.C. Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome. Science 2008, 321:839-843.
23. Momose T., Tonegawa A., Takeuchi J., Ogawa H., Umesono K., Yasuda K. Efficient targeting of gene expression in chick embryos by microelectroporation. Develop. Growth Differ. 1999, 41:335-344.
24. Murray A., Naeem A., Barnes S.H., Drescher U., Guthrie S. Slit and Netrin-1 guide cranial motor axon pathfinding via Rho-kinase, myosin light chain kinase and myosin II. Neural Dev. 2010, 5:16.
25. Nakashima-Yasuda H., Uryu K., Robinson J., Xie S.X., Hurtig H., Duda J.E., Arnold S.E., Siderowf A., Grossman M., Leverenz J.B., Woltjer R., Lopez O.L., Hamilton R., Tsuang D.W., Galasko D., Masliah E., Kaye J., Clark C.M., Montine T.J., Lee V.M., Trojanowski J.Q. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007, 114:221-229.
26. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
27. Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.-C., Sun E., Wancewicz E., Mazur C., Kordasiewicz H., Sedaghat Y., Donohue J.P., Shiue L., Bennett C.F., Yeo G.W., Cleveland D.W. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011, 14:459-468.
28. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L., Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008, 4:e1000193.
29. Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P., Herz J., Yu G. TDP-43 is a developmentally-regulated protein essential for early embryonic development. J. Biol. Chem. 2010, 285:6826-6834.
30. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
31. Strong M.J. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J. Neurol. Sci. 2010, 288:1-12.
32. Strong M.J., Volkening K., Hammond R., Yang W., Strong W., Leystra-Lantz C., Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 2007, 35:320-327.
33. Swarup V., Phaneuf D., Bareil C., Robertson J., Rouleau G.A., Kriz J., Julien J.-P. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 2011, 134:2610-2626.
34. Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., Patani R., Chandran S., Rot G., Zupan B., Shaw C.E., Ule J. (a). Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011, 14:452-458.
35. Tollervey J.R., Wang Z., Hortobágyi T., Witten J.T., Zarnack K., Kayikci M., Clark T.A., Schweitzer A.C., Rot G., Curk T., Zupan B., Rogelj B., Shaw C.E., Ule J. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res. 2011, 21:1572-1582.
36. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., Steinbart E., McCluskey L., Grossman M., Neumann M., Wu I.L., Yang W.S., Kalb R., Galasko D.R., Montine T.J., Trojanowski J.Q., Lee V.M., Schellenberg G.D., Yu C.E. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008, 7:409-416.
37. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
38. Voigt A., Herholz D., Fiesel F.C., Kaur K., Muller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T., Schulz J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS One 2010, 5:e12247.
39. Volkening K., Leystra-Lantz C., Strong M.J. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans. Amyotroph. Lateral Scler. 2009, 1-7.
40. Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18809-18814.
41. Wu L.-S., Cheng W.-C., Hou S.-C., Yan Y.-T., Jiang S.-T., Shen C.K.J. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 2010, 48:56-62.
42. Yokoseki A., Shiga A., Tan C.F., Tagawa A., Kaneko H., A, K., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., Okamoto K., Nishizawa M., Takahashi H., Onodera O. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 2008, 63:538-542.